ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Governor Newsom Signs Bill to Protect Biomedical Research

On Friday, September 25th, Governor Newsom signed AB 713 a measure introduced by Assembly member Kevin Mullin (D-South San Francisco). The bill provides necessary fixes to the California Consumer Privacy Act (CCPA) passed in 2018.  The cleanup is specific to healthcare and goes into effect immediately under an urgency clause. CLSA was actively involved in a coalition with our partners at AdvaMed and we thank the coalition’s efforts for their support of this bill throughout a sometime turbulent process.  We especially want to thank the author for his leadership and commitment to the life sciences sector.

In other news, Governor Newsom also signed AB 2199 by Asm. Nazarian. This bill will help facilitate the creation of more plasma collection centers in California by extending the date of a successful pilot program that authorizes the use of certain qualified personnel in these centers. California currently lags significantly behind other states in the number of plasma collection centers.  Due to COVID 19, plasma donations are down, highlighting the need for California to take the lead in establishing more plasma collection centers.  The urgent need was one of the reasons AB 2199 was one of the few bills considered by the Legislature this session. Also, these plasma collection centers provide excellent entry-level positions in the life sciences sector and provide significant tax revenues to the local economies.  CLSA took a SUPPORT position on AB 2199 and provided testimony during the legislative committee process.

Another bill signed last week was AB 2821 by Asm. Nazarian. This bill would extend the Richard Paul Hemann Parkinson’s Disease Program, which, among other things, requires the State Department of Public Health to collect data on the incidence of Parkinson’s disease in California. The program requires a hospital, facility, physician, and surgeon, or other health care provider diagnosing or providing treatment to Parkinson’s disease patients to report each case of Parkinson’s disease to the department.

Some of the key bills still pending the Governor’s action (deadline is September 30th):

AB 979 (Holden) – Corporation Board of Directors: Underrepresented communities

AB 2100 (Wood) – Medi-Cal: pharmacy benefits

SB 852 (Pan) – Health care: prescription drugs

SB 972 (Skinner) – Corporation Taxes: Disclosure